- Active not recruitingPHASE1
Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours
This study looks at how your body handles a new cancer drug called cediranib when you also take a common medicine called rifampicin. It helps researchers understand how these drugs work together in patients with advanced solid tumours, aiming for safer and more effective treatments.
For: Solid TumorsCanada · United Kingdom - Active not recruitingPHASE2
Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors
This study looks at new drug combinations for certain advanced cancers. It aims to understand how these drugs affect cancer at a genetic level and in the body. It combines an immunotherapy drug with another type of cancer drug.
For: Mismatch Repair Proficient Colorectal Cancer · Pancreatic Adenocarcinoma · LeiomyosarcomaCanada